Abstract
Purpose
Surgeons are increasingly confronted by patients on long-term low-dose acetylsalicylic acid (ASA). However, owing to a lack of evidence-based data, a widely accepted consensus on the perioperative management of these patients in the setting of non-cardiac surgery has not yet been reached. Primary objective was to evaluate the safety of continuous versus discontinuous use of ASA in the perioperative period in elective general or abdominal surgery.
Methods
Fifty-two patients undergoing elective cholecystectomy, inguinal hernia repair or colonic/colorectal surgery were recruited to this pilot study. According to cardiological evaluation, non-high-risk patients who were on long-term treatment with low-dose ASA were eligible for inclusion. Patients were allocated randomly to continuous use of ASA or discontinuation of ASA intake for 5 days before until 5 days after surgery. The primary outcome was the incidence of major haemorrhagic and thromboembolic complications within 30 days after surgery.
Results
A total of 26 patients were allocated to each study group. One patient (3.8%) in the ASA continuation group required re-operation due to post-operative haemorrhage. In neither study group, further bleeding complications occurred. No clinically apparent thromboembolic events were reported in the ASA continuation and the ASA discontinuation group. Furthermore, there were no significant differences between both study groups in the secondary endpoints.
Conclusions
Perioperative intake of ASA does not seem to influence the incidence of severe bleeding in non-high-risk patients undergoing elective general or abdominal surgery. Further, adequately powered trials are required to confirm the findings of this study.
Similar content being viewed by others
References
Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA (2008) An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 372(9633):139–144
Devereaux PJ, Xavier D, Pogue J, Guyatt G, Sigamani A, Garutti I, Leslie K, Rao-Melacini P, Chrolavicius S, Homer Y et al (2011) Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery. Ann Intern Med 154(8):523–528
Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH (2005) Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 173(6):627–634
Devereaux PJ, Goldman L, Yusuf S, Gilbert K, Leslie K, Guyatt GH (2005) Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review. CMAJ 173(7):779–788
Welsch T, Eisele H, Zschäbitz S, Hinz U, Büchler M, Wente M (2011) Critical appraisal of the International Study Group of Pancreatic Surgery (ISGPS) consensus definition of postoperative hemorrhage after pancreatoduodenectomy. Langenbeck's Archiv Surg 396:783–791
Wei AC, Tung-Ping Poon R, Fan ST, Wong J (2003) Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg 90(1):33–41
Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236(4):397–407
de Boer MT, Molenaar IQ, Porte RJ (2007) Impact of blood loss on outcome after liver resection. Dig Surg 24(4):259–264
Antithrombotic Trialists’ Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324(7329):71–86
Mahla ELT, Vicenzi MN, Werkgartner G, Maier R, Probst C, Metzler H (2001) Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery. Anesth Analg 92(3):572–577
Samama CM, Thiry D, Elalamy I, Diaby M, Guillosson J-J, Kieffer E, Coriat P (2001) Perioperative activation of hemostasis in vascular surgery patients. Anesthesiology 94(1):74–78
Collet JP, Montalescot G, Blanchet B, Tanguy ML, Golmard JL, Choussat R, Beygui F, Payot L, Vignolles N, Metzger JP et al (2004) Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 110(16):2361–2367
Biondi-Zoccai GGL, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, Testa L, Sheiban I, Sangiorgi G (2006) A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease. Eur Heart J 27(22):2667–2674
Maulaz AB, Bezerra DC, Michel P, Bogousslavsky J (2005) Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol 62(8):1217–1220
ACC/AHA (2004) Guideline update for coronary artery bypass graft surgery. Circulation 110(14):e340–e437
Howard-Alpe GM, de Bono J, Hudsmith L, Orr WP, Foex P, Sear JW (2007) Coronary artery stents and non-cardiac surgery. Br J Anaesth 98(5):560–574
McFadden EP, Stabile E, Regar E, Cheneau E, Ong ATL, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM et al (2004) Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364(9444):1519–1521
Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE (2000) Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35(5):1288–1294
Schouten O, Bax JJ, Poldermans D (2007) Management of patients with cardiac stents undergoing noncardiac surgery. Curr Opin Anesthesiol 20(3):274–278, 210.1097/ACO.1090b1013e328105dac328105
Murphy JT, Fahy BG (2005) Thrombosis of sirolimus-eluting coronary stent in the postanesthesia care unit. Anesth Analg 101(4):971–973
Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M et al (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293(17):2126–2130
Sharma AK, Ajani AE, Hamwi SM, Maniar P, Lakhani SV, Waksman R, Lindsay J (2004) Major noncardiac surgery following coronary stenting: when is it safe to operate? Catheter Cardiovasc Interv 63(2):141–145
Steinhubl SR, Berger PB, Mann JT, Fry ETA, DeLago A, Wilmer C, Topol EJ, Investigators ftC (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. JAMA 288(19):2411–2420
Chassot P-G, Delabays A, Spahn DR (2007) Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 99(3):316–328
Vicenzi MN, Meislitzer T, Heitzinger B, Halaj M, Fleisher LA, Metzler H (2006) Coronary artery stenting and non-cardiac surgery—a prospective outcome study. Br J Anaesth 96(6):686–693
Korte W, Cattaneo M, Chassot PG, Eichinger S, von Heymann C, Hofmann N, Rickli H, Spannagl M, Ziegler B, Verheugt F, Huber K (2011) Peri-operative management of antiplatelet therapy in patients with coronary artery disease. Joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC). Thromb Haemost 105(5):743–749
Burger W, Chemnitius JM, Kneissl GD, Rücker G (2005) Low-dose aspirin for secondary cardiovascular prevention—cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation—review and meta-analysis. J Intern Med 257(5):399–414
O’Brien JR (1968) Effect of salicylates on human platelets. Lancet 1:779–783
Beving H, Zhao C, Albage A, Ivert T (1996) Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment. Blood Coagul Fibrinolysis 7(1):80–84
Colwell JA (2004) Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus. Am J Cardiovasc Drugs 4(2):87–106
Drouet L, Balditsollier C, Henry P (2010) Antiagrégants plaquettaires et diabète. Ann Cardiol Angeiol 59(Supplement 2):S56–S64
Butalia S, Leung A, Ghali W, Rabi D (2011) Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Diabetol 10(1):25
Horowitz N, Brenner B (2007) Thrombophilia and cancer. Pathophysiol Haemost Thromb 36(3–4):131–136
Rickles FR, Shoji M, Abe K (2001) The role of the hemostatic system in tumor growth, metastases and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer. Int J Hematol 73:145–150
POISE Study Group, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P (2008) Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371(9627):1839–1847
Landesberg G, Shatz V, Akopnik I, Wolf YG, Mayer M, Berlatzky Y, Weissman C, Mosseri M (2003) Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. J Am Coll Cardiol 42(9):1547–1554
Fleischmann KE, Goldman L, Young B, Lee TH (2003) Association between cardiac and noncardiac complications in patients undergoing noncardiac surgery: outcomes and effects on length of stay. Am J Med 115(7):515–520
Mackey WC, Fleisher LA, Haider S, Sheikh S, Cappelleri JC, Lee WC, Wang Q, Stephens JM (2006) Perioperative myocardial ischemic injury in high-risk vascular surgery patients: incidence and clinical significance in a prospective clinical trial. J Vasc Surg: Official Publ Soc Vasc Surg Int Soc Cardiovasc Surg, North Am Chapter 43(3):533–538
Kumar R, McKinney WP, Raj G, Heudebert GR, Heller HJ, Koetting M, McIntire DD (2001) Adverse cardiac events after surgery. J Gen Intern Med 16(8):507–518
Shah KB, Kleinman BS, Rao TLK, Jacobs HK, Mestan K, Schaafsma M (1990) Angina and other risk factors in patients with cardiac diseases undergoing noncardiac operations. Anesth Analg 70(3):240–247
Badner NH, Knill RL, Brown JE, Novick TV, Gelb AW (1998) Myocardial infarction after noncardiac surgery. Anesthesiology 88(3):572–578
Oscarsson A, Gupta A, Fredrikson M, Järhult J, Nyström M, Pettersson E, Darvish B, Krook H, Swahn E, Eintrei C (2010) To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth 104(3):305–312
Thachil J, Gatt A, Martlew V (2008) Management of surgical patients receiving anticoagulation and antiplatelet agents. Br J Surg 95(12):1437–1448
Di Minno M, Prisco D, Ruocco A, Mastronardi P, Massa S, Di Minno G (2009) Perioperative handling of patients on antiplatelet therapy with need for surgery. Intern Emerg Med 4(4):279–288
Brotman DJ, Bakhru M, Saber W, Aneja A, Bhatt DL, Tillan-Martinez K, Jaffer AK (2007) Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: a retrospective cohort study. J Hosp Med 2(6):378–384
O’Riordan JM, Margey RJ, Blake G, O’Connell PR (2009) Antiplatelet agents in the perioperative period. Arch Surg 144(1):69–76
Metzler H, Kozek-Langenecker S, Huber K (2008) Antiplatelet therapy and coronary stents in perioperative medicine—the two sides of the coin. Best Pract Res Clin Anaesthesiol 22(1):81–94
Servin F (2007) Low-dose aspirin and clopidogrel: how to act in patients scheduled for day surgery. Curr Opin Anesthesiol 20(6):531–534, 510.1097/ACO.1090b1013e3282f1015f1095
Merritt JC, Bhatt DL (2004) The efficacy and safety of perioperative antiplatelet therapy. J Thromb Thrombolysis 17(1):21–27
DA Chassot PG, Spahn DR (2007) Perioperative use of anti-platelet drugs. Best Pract Res Clin Anaesthesiol 21(2):241–256
Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR et al (2007) ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 50(17):1707–1732
Collins R, Scrimgeour A, Yusuf S, Peto R (1988) Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 318(18):1162–1173
Tuman KJ, McCarthy RJ, O’Connor CJ, McCarthy WE, Ivankovich AD (1996) Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery. Anesth Analg 83(6):1178–1184
Reich DL, Patel GC, Vela-Cantos F, Bodian C, Lansman S (1994) Aspirin does not increase homologous blood requirements in elective coronary bypass surgery. Anesth Analg 79(1):4–8
Michlig C, Vu DH, Wasserfallen JB, Spahn DR, Schneider P, Tissot JD (2003) Three years of haemovigilance in a general university hospital. Transfus Med 13(2):63–72
Lindblad B, Persson N, Takolander R, Bergqvist D (1993) Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebo-controlled randomized trial. Stroke 24(8):1125–1128
Neilipovitz DT, Bryson GL, Nichol G (2001) The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg 93(3):573–580
Manning BJ, O’Brien N, Aravindan S, Cahill RA, McGreal G, Redmond HP (2004) The effect of aspirin on blood loss and transfusion requirements in patients with femoral neck fractures. Injury 35(2):121–124
Nuttall GA, Santrach PJ, Oliver WC, Horlocker TT, Shaughnessy WJ, Cabanela ME, Bryant S (1996) The predictors of red cell transfusions in total hip arthroplasties. Transfusion 36(2):144–149
Palmer JD, Sparrow OC, Iannotti F (1994) Postoperative hematoma: a 5-year survey and identification of avoidable risk factors. Neurosurgery 35(6):1061–1065
Belisle S, Hardy J-F (1996) Hemorrhage and the use of blood products after adult cardiac operations: myths and realities. Ann Thorac Surg 62(6):1908–1917
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
D. Antolovic and A. Rakow contributed equally to the study.
Rights and permissions
About this article
Cite this article
Antolovic, D., Rakow, A., Contin, P. et al. A randomised controlled pilot trial to evaluate and optimize the use of anti-platelet agents in the perioperative management in patients undergoing general and abdominal surgery—the APAP trial (ISRCTN45810007). Langenbecks Arch Surg 397, 297–306 (2012). https://doi.org/10.1007/s00423-011-0867-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-011-0867-7